Clinical Trial

Study of HS235 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF)

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Study of HS235 in Obese Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction Utilizing Ambulatory Pulmonary Artery Pressure Monitoring
Trial Details
NCT Number NCT07123779
Lead Sponsor 35Pharma Inc
Conditions Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction
Enrollment 40 participants
Start Date 2025-09
Primary Completion 2027-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2025-08-14